Therapeutic development for human diseases continues to face obstacles, particularly in translating targets or compounds identified by in vitro screening campaigns to valid targets or efficacious and safe compounds once tested in humans.
In this webinar we will discuss strategies that leverage induced pluripotent stem cells (iPSCs) to increase the relevance of human cell models for these in vitro approaches.
Focus will be given to how current advances in genome engineering tools are helping to overcome challenges with delivery, identification and selection and subsequent clonal outgrowth. To consistently and reliably generate knock-out and knock-in models for use in target or compound identification.
Attend this webinar to:
Discover effective strategies for building disease models predictive of in vitro and in vivo results leveraging iPSCs
Review current advances in genome engineering
Walk away with a reproducible workflow for successful development of disease models utilizing genome editing and stem cells
Erik Willems Staff Scientist
Thermo Fisher Scientific
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK